Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 20
Filtrar
1.
Support Care Cancer ; 23(7): 1933-9, 2015 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-25492636

RESUMO

PURPOSE: The aim of our study is firstly to evaluate the prevalence and prognostic value of nutrition risk in gastric cancer patients and secondly to explore whether the nutrition support can prolong the survival of advanced gastric cancer patients. METHODS: It contained two study periods. In the first period, we prospectively evaluated the nutritional risk of gastric adenocarcinoma patients from 2009 to 2011 using the method of European Nutritional Risk Screening (NRS) 2002. The Kaplan-Meier method and log-rank test were used to evaluate the prognostic value of high nutrition risk. The second period was between 2012 and 2013. We prospectively gave the nutrition support to stage IV gastric cancer patients whose NRS is ≥3. RESULTS: There were 830 patients in the first period, 50.7% patients with a NRS ≥ 3. Patients with NRS ≥ 3 presented a significantly higher percentage of stage IV diseases, elevated values of C-reactive protein, and hypoproteinemia. The median survival was significantly higher in NRS < 3 patients (31.9 vs. 25.7 months, P < 0.001). Multivariate analysis confirmed that NRS status was an independent prognostic factor. There were 347 patients in the second period. Young, male, and good response to chemotherapy were more likely to have the NRS shift to <3 after nutrition support. The median survival was 14.3 and 9.6 months for patients with and without NRS shift, respectively, P = 0.001. CONCLUSIONS: NRS ≥ 3 was an independent adverse prognostic factor in gastric cancer patients. For stage IV patients whose NRS ≥ 3, the nutrition support might be helpful to improve the prognosis.


Assuntos
Adenocarcinoma/dietoterapia , Adenocarcinoma/tratamento farmacológico , Apoio Nutricional/métodos , Neoplasias Gástricas/dietoterapia , Neoplasias Gástricas/tratamento farmacológico , Adenocarcinoma/metabolismo , Proteína C-Reativa/metabolismo , Feminino , Humanos , Hipoproteinemia/metabolismo , Masculino , Pessoa de Meia-Idade , Estado Nutricional , Prognóstico , Ensaios Clínicos Controlados Aleatórios como Assunto , Fatores de Risco , Neoplasias Gástricas/metabolismo , Análise de Sobrevida
2.
Obes Surg ; 22(9): 1427-36, 2012 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-22798263

RESUMO

Proximal Roux-en Y gastric bypass (RYGB) representing the most frequently performed bariatric procedure yields a weight loss failure rate of around 20 %. In order to reduce failure rates, we established a novel distal RYGB variant characterized by a very long alimentary (Roux) limb and a short common channel. Up to 5 years, follow-up data (complication rates, weight loss, nutritional/metabolic changes) of the first 355 patients (mean ± SD preoperative age, 41.4 ± 10.8 years; BMI, 48.5 ± 11.5 kg/m(2)) who underwent the novel Distal Very Long Roux-en Y Gastric Bypass (DVLRYGB) were analysed. Overall follow-up rate was 98.9 %, mean follow-up time 1.6 ± 1.4 years. Limb lengths were as follows: common channel 76 ± 7 cm, biliopancreatic limb 79 ± 14 cm, and alimentary (Roux) limb 604 ± 99 cm. The operation was performed laparoscopically in 95.2 % of the cases. Thirty-day mortality was zero; major and minor complication rate was 4.5 % and 10.4 %, respectively. Average excess weight loss (EWL) was >74 % 3, 4, and 5 years after the operation and failure rate defined by an EWL < 50 % remained < 6 %. Annually blood measurements revealed a relatively low incidence rate of severe nutritional deficiencies, but mild anaemia and hypoproteinemia were frequently observed. Laparoscopic revision with a proximalization of the lower anastomosis was required in 4 (1.1 %) patients. Data indicate that our DVLRYGB leads to excellent weight loss results. Furthermore, within the setting of a structured multidisciplinary follow-up program, the incidence of severe malnutrition states was relatively low.


Assuntos
Anemia/etiologia , Derivação Gástrica/efeitos adversos , Derivação Gástrica/métodos , Hipoproteinemia/etiologia , Desnutrição/etiologia , Obesidade Mórbida/cirurgia , Redução de Peso , Adulto , Algoritmos , Índice de Massa Corporal , Suplementos Nutricionais , Feminino , Seguimentos , Humanos , Hipoproteinemia/metabolismo , Absorção Intestinal , Masculino , Desnutrição/metabolismo , Doenças Metabólicas/etiologia , Doenças Metabólicas/metabolismo , Obesidade Mórbida/complicações , Resultado do Tratamento
3.
Proc Natl Acad Sci U S A ; 103(13): 5084-9, 2006 Mar 28.
Artigo em Inglês | MEDLINE | ID: mdl-16549777

RESUMO

Two siblings, products of a consanguineous marriage, were markedly deficient in both albumin and IgG because of rapid degradation of these proteins, suggesting a lack of the neonatal Fc receptor, FcRn. FcRn is a heterodimeric receptor composed of a nonclassical MHC class I alpha-chain and beta(2)-microglobulin (beta(2)m) that binds two ligands, IgG and albumin, and extends the catabolic half-lives of both. Eight relatives of the siblings were moderately IgG-deficient. From sera archived for 35 years, we sequenced the two siblings' genes for the heterodimeric FcRn. We found that, although the alpha-chain gene sequences of the siblings were normal, the beta(2)m genes contained a single nucleotide transversion that would mutate a conserved alanine to proline at the midpoint of the signal sequence. Concentrations of soluble beta(2)m and HLA in the siblings' sera were <1% of normal. Transfection assays of beta(2)m-deficient cultured cells with beta(2)m cDNA indicated that the mutant beta(2)m supported <20% of normal expression of beta(2)m, MHC class I, and FcRn proteins. We concluded that a beta(2)m gene mutation underlies the hypercatabolism and reduced serum levels of albumin and IgG in the two siblings with familial hypercatabolic hypoproteinemia. This experiment of nature affirms our hypothesis that FcRn binds IgG and albumin, salvages both from a degradative fate, and maintains their physiologic concentrations.


Assuntos
Antígenos de Histocompatibilidade Classe I/metabolismo , Hipoproteinemia/genética , Hipoproteinemia/metabolismo , Receptores Fc/deficiência , Receptores Fc/metabolismo , Microglobulina beta-2/genética , Microglobulina beta-2/metabolismo , Sequência de Aminoácidos , Sequência de Bases , Linhagem Celular Tumoral , Suscetibilidade a Doenças , Regulação da Expressão Gênica , Antígenos de Histocompatibilidade Classe I/genética , Humanos , Hipoproteinemia/patologia , Dados de Sequência Molecular , Mutação/genética , Receptores Fc/genética , Microglobulina beta-2/química
4.
Int Surg ; 79(2): 152-7, 1994.
Artigo em Inglês | MEDLINE | ID: mdl-7928151

RESUMO

OBJECTIVE: Analysis of severity, causes and relevance of hypalbuminaemia developing after surgery. SUBJECTS: Patients undergoing elective aortic surgery (n = 11) or minor extra-abdominal surgery (n = 6). METHODS: Serum albumin concentration, blood loss, nitrogen balance and complications were determined until the fifth post-operative day. The contributions of haemodilution, albumin loss, albumin catabolism and redistribution were calculated using existing formula. The relation of hypalbuminaemia to the endocrine-metabolic response was determined. RESULTS: Significant hypalbuminaemia occurred after aortic surgery, in the absence of significant complications. No haemodilution occurred. Analysis indicated that 18% of hypalbuminaemia was caused by blood loss. Only 6% could be attributed to albumin catabolism, despite a significant correlation with the endocrine-metabolic response. Seventy-seven percent of hypalbuminaemia was attributed to albumin redistribution. No hypalbuminaemia occurred after minor surgery. CONCLUSION: Post-operative hypalbuminaemia is a normal finding early after aortic surgery. It is mainly caused by albumin redistribution, not by metabolic changes.


Assuntos
Abdome/cirurgia , Aorta Abdominal/cirurgia , Hipoproteinemia/etiologia , Complicações Pós-Operatórias , Albumina Sérica/deficiência , Perda Sanguínea Cirúrgica , Volume Sanguíneo , Procedimentos Cirúrgicos Eletivos , Hemodiluição , Humanos , Hidrocortisona/sangue , Hipoproteinemia/sangue , Hipoproteinemia/metabolismo , Masculino , Procedimentos Cirúrgicos Menores , Nitrogênio/metabolismo , Albumina Sérica/análise , Albumina Sérica/metabolismo
5.
Eur J Clin Chem Clin Biochem ; 31(2): 103-6, 1993 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-8096769

RESUMO

The amino acid pattern in the ascites of 79 dogs was examined. The concentration of glutamine in neoplastic ascites is significantly lower than in cardial effusions. In contrast, glutamate is significantly higher in neoplastic ascites than in cardial ascites. Using an arbitrary discrimination value of 0.28 for the glutamate/glutamine ratio, purulent or cardial ascites are easily differentiated, with a sensitivity of 100% and a specificity of 94%. The differentiation is very distinct, with no overlap between the group of patients with liver cirrhosis on the one hand and the groups of patients with purulent peritonitis, heart failure, or malignant ascites on the other hand. There was no diagnostically unsable correlation between the concentrations of the other 20 amino acids and the underlying causes of ascites formation.


Assuntos
Líquido Ascítico/metabolismo , Glutamatos/metabolismo , Glutamina/metabolismo , Aminoácidos/metabolismo , Animais , Ascite/metabolismo , Ascite/veterinária , Doenças do Cão/diagnóstico , Doenças do Cão/metabolismo , Cães , Ácido Glutâmico , Insuficiência Cardíaca/metabolismo , Insuficiência Cardíaca/veterinária , Hipoproteinemia/metabolismo , Hipoproteinemia/veterinária , Cirrose Hepática/metabolismo , Cirrose Hepática/veterinária , Neoplasias/metabolismo , Neoplasias/veterinária , Peritonite/metabolismo , Peritonite/veterinária
6.
Crit Care Med ; 17(7): 657-60, 1989 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-2500300

RESUMO

Previous studies have confirmed the improved tolerance of a peptide enteral compared to standard enteral alimentation in hypoalbuminemic, critically ill patients. Animal studies, including hypoproteinemic, volume-expanded rats, demonstrated that the protein hydrolysate of a peptide enteral formula was responsible for the enhanced absorption. The purpose of this study was to determine whether the composition of small MW peptides (protein hydrolysate) in two commercially available peptide enteral formulas would affect the rate of intestinal absorption and albumin clearance in intact jejunal loops before and during hypoproteinemia induced by iv infusion of Tyrode's solution in Sprague-Dawley rats. Net transmucosal water movement was calculated using a volume recovery method; albumin clearance was calculated using iv radiolabeled albumin. We studied three groups of animals during luminal perfusion with either Tyrode's solution, diet A containing 21% peptides, or diet B containing 56% peptides. When compared to luminal perfusion with Tyrode's solution (control animals), both diets significantly enhanced net transmucosal water absorption before volume expansion (p less than .05). With the induction of hypoproteinemia, diet B continued to stimulate water absorption when compared to control animals (p less than .01). Luminal perfusion with diet A failed to attenuate net water secretion induced by hypoproteinemia. Capillary and mucosal albumin clearance was similar for all groups studied. These findings suggest the percentage of small MW peptides may affect the rate of intestinal absorption in patients with acute kwashiorkor-like hypoalbuminemia.


Assuntos
Alimentos Formulados , Hipoproteinemia/metabolismo , Absorção Intestinal , Peptídeos/administração & dosagem , Animais , Água Corporal/metabolismo , Nutrição Enteral , Hipoproteinemia/induzido quimicamente , Soluções Isotônicas , Masculino , Peptídeos/metabolismo , Ratos , Ratos Endogâmicos
7.
Gan No Rinsho ; 35(6): 709-16, 1989 May.
Artigo em Japonês | MEDLINE | ID: mdl-2498553

RESUMO

In order to determine the nutritional effects of BCAA compositions in the treatment of cancerous hypoproteinemia, the appropriate ratio of I-leu: Leu: Val and the proportion of BCAA to Total Amino Acids were investigated. As for results, indices such as the serum albumin, the RBP and N-balance quickly recovered to normal levels when the ratio of I-leu: Leu: Val was 1.0:1.8:1.0 and the proportion o BCAA to TAA was 31%. These composition thus may be suitable for the treatment of cancerous hypoproteinemia.


Assuntos
Aminoácidos de Cadeia Ramificada/uso terapêutico , Aminoácidos/metabolismo , Hipoproteinemia/terapia , Neoplasias/complicações , Nutrição Parenteral Total , Aminoácidos/sangue , Aminoácidos de Cadeia Ramificada/administração & dosagem , Feminino , Humanos , Hipoproteinemia/etiologia , Hipoproteinemia/metabolismo , Isoleucina/administração & dosagem , Isoleucina/uso terapêutico , Leucina/administração & dosagem , Leucina/uso terapêutico , Masculino , Pessoa de Meia-Idade , Nitrogênio/metabolismo , Nutrição Parenteral Total/métodos , Pré-Albumina/metabolismo , Proteínas de Ligação ao Retinol/metabolismo , Transferrina/metabolismo , Valina/administração & dosagem , Valina/uso terapêutico
8.
Int J Oral Surg ; 14(3): 302-6, 1985 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-3926678

RESUMO

One peculiar case of giant ameloblastoma of the mandible is reported in this paper. This case is characterized by 2 interesting points: large tumor size of an infant's head, hypoproteinemia caused by leakage of serum protein, especially albumin, via fistula formed in the gum and edema of the body. Problems accompanying hypoproteinemia are discussed.


Assuntos
Ameloblastoma/complicações , Hipoproteinemia/etiologia , Neoplasias Mandibulares/complicações , Adulto , Ameloblastoma/patologia , Exsudatos e Transudatos/análise , Feminino , Fístula/etiologia , Fístula/metabolismo , Humanos , Hipoproteinemia/metabolismo , Doenças Mandibulares/etiologia , Doenças Mandibulares/metabolismo , Neoplasias Mandibulares/patologia
11.
Gastroenterology ; 71(3): 484-9, 1976 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-133045

RESUMO

Detailed studies of protein metabolism were undertaken in a patient with pellagra and hypoproteinemia associated with the carcinoid syndrome both before and after treatment. The synthesis of albumin improved from 82 mg per kg per day to 135 mg per kg per day with little change in the daily excretion of 5-hydroxyindole acetic acid. After treatment with nicotinamide the patient made good progress with a complete resolution of the signs of pellagra and protein malnutrition. These results support the hypothesis that a reduced availability of the essential amino acid L-tryptophan may limit the synthesis of albumin and nicotinic acid in patients with the carcinoid syndrome who become anoretic.


Assuntos
Hipoproteinemia/metabolismo , Síndrome do Carcinoide Maligno/metabolismo , Pelagra/metabolismo , Albumina Sérica/metabolismo , Triptofano/metabolismo , Adulto , Peso Corporal , Feminino , Humanos , Hipoproteinemia/tratamento farmacológico , Síndrome do Carcinoide Maligno/sangue , Síndrome do Carcinoide Maligno/complicações , Niacinamida/uso terapêutico , Pelagra/tratamento farmacológico , Soroalbumina Radioiodada/metabolismo , Triptofano/sangue , Triptofano/deficiência
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA